Pharmacologic profile of zoledronic acid: A highly potent inhibitor of bone resorption.
- Published in:
- Drug Development Research, 2002, v. 55, n. 4, p. 210, doi. 10.1002/ddr.10071
- By:
- Publication type:
- Article
Works matching IS 02724391 AND DT 2002 AND VI 55 AND IP 4
Results: 4
1
2
Biochemical profile of anseculin (KA-672) at different brain receptors.
- Published in:
- Drug Development Research, 2002, v. 55, n. 4, p. 187, doi. 10.1002/ddr.10053
- By:
- Publication type:
- Article
3
Abstracts of the presentations at the international symposium: Cardiovascular remodeling, ion channelopathies, arrhythmias, and drug treatment, September 25-27, 2001.
- Published in:
- Drug Development Research, 2002, v. 55, n. 4, p. 225, doi. 10.1002/ddr.10052
- By:
- Publication type:
- Article
4
Targeted replacement of rodent CCR2 with the human orthologue CCR2B: A mouse model for in vivo analysis of human target-selective small molecule MCP-1 receptor antagonists.
- Published in:
- Drug Development Research, 2002, v. 55, n. 4, p. 197, doi. 10.1002/ddr.10044
- By:
- Publication type:
- Article